Ken Griffin
CRVO icon

Ken Griffin’s CervoMed CRVO Stock Holding History

Ken Griffin’s Portfolio CRVO Stock Details CRVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-49,250
Closed -$389K – 13148
2025
Q4 		$389K Buy
49,250
+18,740
+61% +$151K ﹤0.01% 9598
2025
Q3 		$247K Buy
+30,510
New +$262K ﹤0.01% 10787
2025
Q1 		– Sell
-10,811
Closed -$25.3K – 14620
2024
Q4 		$25.3K Sell
10,811
-1,682
-13% -$16.4K ﹤0.01% 13022
2024
Q3 		$182K Buy
+12,493
New +$194K ﹤0.01% 10296
2023
Q2 		– Sell
-12,438
Closed -$77.6K – 14451
2023
Q1 		$77.6K Buy
+12,438
New +$110K ﹤0.01% 11603
2021
Q4 		– Sell
-1,559
Closed -$60K – 13892
2021
Q3 		$60K Sell
1,559
-456
-23% -$19K ﹤0.01% 13262
2021
Q2 		$110K Buy
+2,015
New +$111K ﹤0.01% 12831
2021
Q1 		– Sell
-1,061
Closed -$63K – 13220
2020
Q4 		$63K Buy
1,061
+359
+51% +$21K ﹤0.01% 10473
2020
Q3 		$44K Buy
+702
New +$53.4K ﹤0.01% 9646
2019
Q1 		– Sell
-177
Closed -$26K – 9330
2018
Q4 		$26K Buy
+177
New +$60.4K ﹤0.01% 8661
2018
Q3 		– Sell
-37
Closed -$19K – 9261
2018
Q2 		$19K Buy
+37
New +$21.9K ﹤0.01% 8659

Other funds holding CRVO

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
CFG
Citizens Financial Group Providence, Rhode Island $8.3B AUM 27.66% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Ken Griffin's CRVO Position: Q1 2026 in Review

Ken Griffin sold out of CervoMed (CRVO) in Q1 2026, closing a stake of 49,250 shares — an estimated $389K sold.

Ken Griffin first reported a position in CRVO in Q2 2018 and held it in 11 quarters. The position peaked at $389K in Q4 2025. 36 funds tracked by Wall St. Rank hold CRVO as of Q1 2026.

  • Ken Griffin reported no remaining CervoMed position as of Q1 2026 after selling out during the quarter.
  • Ken Griffin sold 49,250 CervoMed shares in Q1 2026, an estimated $389K.
  • Ken Griffin first reported a position in CervoMed in Q2 2018 and held it in 11 quarters.
  • Ken Griffin's CervoMed position peaked at $389K in Q4 2025.
  • 36 funds tracked by Wall St. Rank held CervoMed as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.